HK$37.06-2.22% · 3M
Moving avg
1W+1.04%
1M-5.84%
3M-2.22%
6M-23.43%
YTD-34.23%
1Y-42.45%
3Y-16.15%
5Y-52.64%
52-week range
$4.0613% of range$9.14
Company health
Value4/6
Growth6/6
Profitability3/6
Health6/6
Dividend0/6
Bull vs bear
Strengths
- High return on equity (1015%)
- Revenue compounding 38% a year
- Net cash on the balance sheet
Risks
No obvious red flags from the metrics.
Key statistics
Valuation
Market cap
$15.18B
Enterprise value
$10.82B
P/E ratio (TTM)
16.94x
P/S ratio (TTM)
1.33x
EV/EBITDA
16.89x
Per share & returns
EPS (TTM)
$0.25
Dividend yield
0.00%
Beta (1Y)
1.18
30-day change
-5.84%
Trading
Volume (24h)
7.44M
Previous close
HK$36.00
Shares outstanding
3.21B
About JD Health International Inc.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Exchange
HKEX
Symbol
6618.HK
JD Health International Inc. is a large-cap healthcare company in the Medical - Pharmaceuticals industry.
Frequently asked questions
What is JD Health International Inc.'s market cap?
JD Health International Inc. (6618.HK) has a market capitalization of $15.18B.
What is JD Health International Inc.'s P/E ratio?
JD Health International Inc. trades at a price-to-earnings (P/E) ratio of 16.94.
What exchange does 6618.HK trade on?
6618.HK trades on HKEX.
Appears in
Eli Lilly and CompanyLLY
$1,148.20-0.98%
$1.08T cap
Johnson & JohnsonJNJ
$275.23-1.15%
$663.28B cap
AbbVie Inc.ABBV
$256.34-1.49%
$452.90B cap
Merck & Co., Inc.MRK
$150.34-1.31%
$371.31B cap
UnitedHealth Group IncorporatedUNH
$397.14-0.95%
$360.66B cap
Roche Holding AGSWX: ROP
CHF 357.00+0.14%
$350.91B cap
Novartis AGSWX: NOVN
CHF 129.58-1.33%
$304.13B cap
AstraZeneca PLCLON: AZN
£120.06-1.15%
$251.66B cap